Evaluation of efficacy and safety of opioid analgesics for patients with cancer pai
- Conditions
- Thoracic Malignancy
- Registration Number
- JPRN-UMIN000011067
- Lead Sponsor
- Department of Respiratory Medicine, Osaka University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Not provided
1) prior history of allergy or hypersensitivity to opioids 2) prior history of opioid abuse 3) clinically significant cardiac, renal or hepatic insufficiency 4) increased intracranial pressure or impaired cognitive function 5) active and extensive skin disease precluding application of the transdermal delivery system 6) persistent fever of 40 degrees Celsius or over 7) pregnancy, lactation and suspicion of being pregnant 8) prior use of any opioid-antagonists within 2 days before switching to fentanyl patch.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method